BioCentury
ARTICLE | Financial News

Aeglea raises $60M follow-on

February 8, 2019 1:55 AM UTC

Human enzyme therapeutic company Aeglea BioTherapeutics Inc. (NASDAQ:AGLE) raised $60 million through the sale of 3.8 million shares at $8 in a follow-on Feb. 6. The price is a 16% discount to Aeglea's close of $9.40 on Feb. 5, before the company announced the offering.

Investors also received prefunded warrants to purchase 3.8 million shares at $8...

BCIQ Company Profiles

Aeglea BioTherapeutics Inc.